Charles Mosseri - 12 Dec 2024 Form 4/A - Amendment Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
10%+ Owner
Signature
/s/ Charles Mosseri-Marlio
Issuer symbol
NVCT
Transactions as of
12 Dec 2024
Net transactions value
+$228,941
Form type
4/A - Amendment
Filing time
16 Dec 2024, 17:37:54 UTC
Date Of Original Report
16 Dec 2024
Previous filing
01 Aug 2023
Next filing
16 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $149,041 +32,121 +1.2% $4.64 2,627,121 12 Dec 2024 Direct
transaction NVCT Common Stock Purchase $79,900 +17,000 +0.65% $4.70 2,644,121 13 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The original Form 4, filed on December 16, 2024, is being amended by this Form 4 amendment to include a transaction that occurred on December 12, 2024, and to correct the amount of securities beneficially owned by the reporting person as a result of the reported transactions.